While a clear trend of benefit from the secondary prophylaxis is observed among those with low immunity, it should be noted that the treatment of these patients requires a multifactorial approach.
← all excerpts
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
1
—
—